Ultan McDermott

Active 2001–2025

87
Papers
45,963
Citations
67
h-index
86
i10-index

Citations

Citations per year for Ultan McDermott1945: 1 citations1948: 1 citations1971: 1 citations1982: 2 citations1983: 3 citations1984: 2 citations1986: 4 citations1987: 5 citations1988: 3 citations1989: 2 citations1990: 2 citations1991: 4 citations1992: 4 citations1993: 10 citations1994: 6 citations1995: 6 citations1996: 5 citations1997: 4 citations1998: 7 citations1999: 2 citations2000: 8 citations2001: 9 citations2002: 6 citations2003: 18 citations2004: 11 citations2005: 10 citations2006: 16 citations2007: 17 citations2008: 37 citations2009: 61 citations2010: 146 citations2011: 241 citations2012: 270 citations2013: 323 citations2014: 522 citations2015: 693 citations2016: 985 citations2017: 1,085 citations2018: 1,120 citations2019: 2,331 citations2020: 2,422 citations2021: 2,350 citations2022: 1,844 citations2023: 1,245 citations2024: 1,751 citations2025: 906 citations2026: 74 citations1946–1947: no citations, so these years are not shown1949–1970: no citations, so these years are not shown1972–1981: no citations, so these years are not shown1985: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 7,506 citing papers, 26.8% of this breakdownChina: 3,133 citing papers, 11.2% of this breakdownUnited Kingdom: 2,288 citing papers, 8.2% of this breakdownGermany: 1,592 citing papers, 5.7% of this breakdownItaly: 1,113 citing papers, 4% of this breakdownNetherlands: 973 citing papers, 3.5% of this breakdownFrance: 940 citing papers, 3.4% of this breakdownCanada: 918 citing papers, 3.3% of this breakdownAustralia: 857 citing papers, 3.1% of this breakdownSpain: 787 citing papers, 2.8% of this breakdownJapan: 771 citing papers, 2.7% of this breakdownSwitzerland: 643 citing papers, 2.3% of this breakdown
0%26.8%Other 23%

Fields

  • Biochemistry, Genetics and Molecular Biology43.7%
  • Medicine43.3%
  • Computer Science5.6%
  • Immunology and Microbiology2.7%
  • Engineering1.4%
  • Agricultural and Biological Sciences0.9%
  • Other2.4%

Topics

  • Cancer Genomics and Diagnostics7.7%
  • Cancer Immunotherapy and Biomarkers3.2%
  • Cancer Cells and Metastasis3.1%
  • Lung Cancer Treatments and Mutations2.7%
  • Computational Drug Discovery Methods2.5%
  • Epigenetics and DNA Methylation2.4%
  • Other78.4%

Coauthors

All papers

Open in search
  1. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells

    Authors: , , , , , , , , , , , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2012 cited by 4,313

  2. Signatures of mutational processes in human cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stian Knappskog, Marcel Kool, Sunil R. Lakhani, Carlos López-Otı́n, Sancha Martin, Nikhil C. Munshi, Hiromi Nakamura, Paul A. Northcott, Marina Pajic, Elli Papaemmanuil, Angelo Paradiso, John V. Pearson, Xosé S. Puente, Keiran Raine, Manasa Ramakrishna, Andrea L. Richardson, Julia Richter, Philip Rosenstiel, Matthias Schlesner, Ton N. Schumacher, Paul N. Span, Jon W. Teague, Yasushi Totoki, Andrew Tutt, Rafael Valdés‐Mas, Marit M. van Buuren, Laura van ‘t Veer, Anne Vincent‐Salomon, Nicola Waddell, Lucy Yates, Jessica Zucman‐Rossi, P. Andrew Futreal, Ultan McDermott, Peter Lichter, Matthew Meyerson, Sean M. Grimmond, Reiner Siebert, Elı́as Campo, Tatsuhiro Shibata, Stefan M. Pfister, Peter J. Campbell, Michael R. Stratton - Nature 2013 cited by 10,246

  3. Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gad Getz, Lodewyk F.A. Wessels, Michael R. Stratton, Ultan McDermott, Matthew Meyerson, Mathew J. Garnett, Hans Clevers - Cell 2015 cited by 2,472

  4. A Landscape of Pharmacogenomic Interactions in Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manel Esteller, Nathanael S. Gray, Daniel A. Haber, Michael R. Stratton, Cyril H. Benes, Lodewyk F.A. Wessels, Julio Sáez-Rodríguez, Ultan McDermott, Mathew J. Garnett - Cell 2016 cited by 2,304

  5. A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations

    Authors: , , , , , , , , , , , , , , , - Cell 2010 cited by 2,813

  6. Systematic identification of genomic markers of drug sensitivity in cancer cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tinghu Zhang, Patrick O’Brien, Jessica L. Boisvert, Stacey Price, Wooyoung Hur, Wanjuan Yang, Xianming Deng, Adam P. Butler, Hwan Geun Choi, Jae Won Chang, José Baselga, Ivan Stamenkovic, Jeffrey A. Engelman, Sreenath V. Sharma, Olivier Delattre, Julio Sáez-Rodríguez, Nathanael S. Gray, Jeffrey Settleman, P. Andrew Futreal, Daniel A. Haber, Michael R. Stratton, Sridhar Ramaswamy, Ultan McDermott, Cyril H. Benes - Nature 2012 cited by 2,601

  7. The evolutionary history of lethal metastatic prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , G. Steven Bova - Nature 2015 cited by 1,455

  8. A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2016 cited by 834

  9. Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mathew J. Garnett, Ultan McDermott, Serena Nik‐Zainal, Peter J. Campbell, Michael R. Stratton - Cell 2019 cited by 450

  10. Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties

    Authors: , , , , , , - PLoS ONE 2013 cited by 567

  11. Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Gut 2020 cited by 272

  12. COSMIC: exploring the world's knowledge of somatic mutations in human cancer

    Authors: , , , , , , , , , , , , , , , , - Nucleic Acids Research, Nucleic Acids Res. 2014 cited by 2,383

  13. Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 cited by 1,882

  14. Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma

    Authors: , , , , , , , , , , , , , , , , , , - Nature Communications 2014 cited by 637

  15. Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jack A. Taylor, D Neil Hayes, David Malkin, ICGC Breast Cancer Group, ICGC Chronic Myeloid Disorders Group, ICGC Prostate Cancer Group, Christopher S. Foster, Anne Y. Warren, Hayley C. Whitaker, Daniel S. Brewer, Rosalind A. Eeles, Colin Cooper, David E. Neal, Tapio Visakorpi, William B. Isaacs, G. Steven Bova, Adrienne M. Flanagan, P. Andrew Futreal, Andy G. Lynch, Patrick F. Chinnery, Ultan McDermott, Michael R. Stratton, Peter J. Campbell - eLife 2014 cited by 500

  16. ctDNA monitoring using patient-specific sequencing and integration of variant reads

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ultan McDermott, Christopher G. Smith, Charles Massie, Pippa Corrie, Nitzan Rosenfeld - Science Translational Medicine 2020 cited by 200

  17. A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2020 cited by 179

  18. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laura Mudie, Claire Hardy, Sancha Martin, Stuart McLaren, Sarah O’Meara, Elizabeth Anderson, Mark Maddison, Stephen J. Gamble, ICGC Breast Cancer Group, ICGC Bone Cancer Group, ICGC Prostate Cancer Group, Christopher S. Foster, Anne Y. Warren, Hayley C. Whitaker, Daniel Brewer, Rosalind A. Eeles, Colin Cooper, David E. Neal, Andy G. Lynch, Tapio Visakorpi, William B. Isaacs, Laura van’t Veer, Carlos Caldas, Christine Desmedt, Christos Sotiriou, Samuel Aparício, John A. Foekens, Jórunn E. Eyfjörd, Sunil R. Lakhani, Gilles Thomas, Ola Myklebost, Paul N. Span, Anne‐Lise Børresen‐Dale, Andrea L. Richardson, Marc J. van de Vijver, Anne Vincent‐Salomon, Gert G. Van den Eynden, Adrienne M. Flanagan, P. Andrew Futreal, Sam M. Janes, G. Steven Bova, Michael R. Stratton, Ultan McDermott, Peter J. Campbell - Science 2014 cited by 443

  19. Pharmacogenomic agreement between two cancer cell line data sets

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2015 cited by 444

  20. Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael R. Stratton, Adrienne M. Flanagan, Peter J. Campbell - Nature Communications 2017 cited by 262

  21. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul C. Boutros, Michael Fraser, Susanna L. Cooke, Keiran Raine, David Jones, Andrew Menzies, Lucy Stebbings, Jon Hinton, Jon W. Teague, Stuart McLaren, Laura Mudie, Claire Hardy, Elizabeth Anderson, Olivia Joseph, Victoria Goody, Ben Robinson, Mark Maddison, Stephen J. Gamble, Christopher Greenman, Daniel M. Berney, Steven Hazell, Naomi Livni, Cyril Fisher, Christopher Ogden, Pardeep Kumar, Alan Thompson, Christopher Woodhouse, David M. Nicol, Erik Mayer, Tim Dudderidge, Nimish Shah, Vincent J. Gnanapragasam, Thierry Voet, Peter J. Campbell, P. Andrew Futreal, Douglas Easton, Anne Y. Warren, Christopher S. Foster, Michael R. Stratton, Hayley C. Whitaker, Ultan McDermott, Daniel S. Brewer, David E. Neal - Nature Genetics 2015 cited by 457

  22. MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell 2012 cited by 434

  23. XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data

    Authors: , , , , , , , , , , , , , , , , - BMC Bioinformatics 2018 cited by 171

  24. Knowledge graph-based recommendation framework identifies drivers of resistance in EGFR mutant non-small cell lung cancer

    Authors: , , , , , , , , , , , , , , - Nature Communications 2022 cited by 94